Home » Australia's Mayne Group to Consider Splitting Its Businesses
Australia's Mayne Group to Consider Splitting Its Businesses
Mayne Group, Australia's largest maker of generic injectable drugs, will consider splitting its businesses. Mayne "is undertaking a strategic review to assess the merits of a demerger involving separate listings of its global pharmaceutical business and an entity focused on its domestic healthcare businesses," the Melbourne-based company said in a statement to the Australian Stock Exchange today.
Bloomberg (http://www.bloomberg.com/apps/news?pid=10000081&sid=ac734L4S53IQ&refer=australia)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May